Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(38%)
Results Posted
25%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_3
1
13%
Ph not_applicable
3
38%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Recruiting2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (20.0%)
Phase 31 (20.0%)
N/A3 (60.0%)

Trials by Status

active_not_recruiting113%
terminated113%
recruiting225%
completed450%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8